Prelude Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,500
| Closed | -$700K | – | 1342 |
|
|
2024
Q2 | $700K | Buy |
2,500
+464
| +23% | +$130K | 0.05% | 347 |
|
|
2024
Q1 | $544K | Sell |
2,036
-964
| -32% | -$257K | 0.03% | 538 |
|
|
2023
Q4 | $694K | Buy |
3,000
+981
| +49% | +$227K | 0.05% | 339 |
|
|
2023
Q3 | $295K | Buy |
2,019
+678
| +51% | +$99K | 0.02% | 568 |
|
|
2023
Q2 | $310K | Buy |
+1,341
| New | +$310K | 0.02% | 539 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1422 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1520 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1577 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1608 |
|
|
2018
Q3 | – | Sell |
-25
| Closed | -$7K | – | 1553 |
|
|
2018
Q2 | $7K | Buy |
+25
| New | +$7K | ﹤0.01% | 1238 |
|